Transplant-Ineligible Symptomatic but Indolent Multiple Myeloma Shows Better Prognosis with Conventional Agents

The survival of multiple myeloma patients has improved significantly over the last several decades. However, the median overall survival of these patients remains less than 5 years. In this report, we discuss 4 cases of multiple myeloma patients that showed long survival. Interestingly, these patien...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Aya Nakaya, Shinya Fujita, Atsushi Satake, Takahisa Nakanishi, Yoshiko Azuma, Yukie Tsubokura, Akiko Konishi, Masaaki Hotta, Hideaki Yoshimura, Kazuyoshi Ishii, Tomoki Ito, Shosaku Nomura
Natura: Artigo
Lingua:Inglês
Pubblicazione: Karger Publishers 2017-10-01
Serie:Case Reports in Oncology
Soggetti:
Indolent
Symptomatic myeloma
Conventional therapy
Absence of deep response
Accesso online:https://www.karger.com/Article/FullText/481166
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi